Development of Novel Immunological-Directed Recombinant Probiotic to Treat Autoimmune Disorders
Time: 2:00 pm
day: Conference Day One Track A PM 1
Details:
- Engineered probiotics that leverage microbiome associated immune pathways to reprogram immunological repertoire
- Specific modulation of the immune response with new oral microbiome-based synthetic biology medicines